Vanderbilt Ingram Cancer Center

A multicenter study led by Vanderbilt University Medical Center (VUMC) investigators found that pancreatic cancer patients who underwent surgery and received chemotherapy lived longer and had fewer cancer recurrences in other parts of the body than patients who also received chemoradiation therapy. Read More

Receiving a cancer diagnosis and undergoing treatment can be an emotional experience for patients, and their families, friends and caregivers are also affected by the experience. Creative writing can provide an outlet to express and share those strong emotions. Read More

Jeremy Warner, M.D., M.S., assistant professor of Medicine and Biomedical Informatics, has been named medical director of the Vanderbilt Cancer Registry at Vanderbilt-Ingram Cancer Center (VICC). Read More

Pink will be the dominant color in Memorial Gymnasium Sunday, Feb. 14, as the Vanderbilt Commodores Women’s Basketball team participates in the annual Pink Out! game to raise awareness about breast cancer. Read More

Vanderbilt-Ingram Cancer Center (VICC) has unveiled a new TrueBeam linear accelerator in the Department of Radiation Oncology on the main campus to provide enhanced radiation therapy for patients. Read More

Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have. Read More

Justin Balko, Pharm.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been named a member of the 2016 class of Pink Tie Guys by the Greater Nashville Affiliate of Susan G. Komen, a nonprofit organization dedicated to breast cancer research and patient support. Read More

Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been named director of Cancer Health Information and Strategy, a new management post that will expand her leadership role. Read More

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI). Read More

In 2005, Tennessee philanthropists Jim and Janet Ayers gave $10 million to help Vanderbilt University scientists find early markers for colorectal cancer that could improve diagnosis and potentially save lives. Read More

Cancer survivors, family and friends rock to tunes performed by Soul Incision during the annual cancer Survivors Day celebration. Read More

Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway. Read More

Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various types of cancer, as well as other diseases. The company has agreed to help fund basic and translational science research by VUMC investigators. Read More

Vanderbilt-Ingram Cancer Center, in partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt, is hosting the 2015 Cancer Survivorship Celebration Sunday, Nov. 1, from 2 to 4 p.m. at the Vanderbilt Student Life Center. Read More

The second annual Courage Unmasked event to raise awareness about head and neck cancer will be held Friday, Oct. 16, 6 – 9 p.m., at the Sarratt Gallery at Vanderbilt. Read More

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support. Read More

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read More

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More

Cancer patients, family members and those who care for cancer patients often need a way to express the deep and often lasting emotions that a cancer diagnosis can bring. Read More